Recursion Pharmaceuticals has announced the pricing of a $200 million public offering of Class A common stock at $6.50 per share. The offering consists of 30.77 million shares and represents a 20% discount to the previous day's share price. The stock is trading at -20.8% pre-market.
In #biotech #stocks news, $RXRX Recursion announced the pricing of $200M of stock at $6.50, around a 20% discount to yesterday's share price. The company recently had their Download event, a way to update people on their progress. Some highlights... https://t.co/3LpkqXPPV0
$RXRX (-20.8% pre) Recursion Pharmaceuticals (RXRX) Prices 30.77M Share Offering at $6.50/sh - SI https://t.co/9Lr2lNW9Sr
Recursion Announces Pricing of $200 Million Public Offering at $6.50 a share. $RXRX https://t.co/qpOoUeBCKT
Recursion Announces Proposed Offering of Class A Common Stock $RXRX https://t.co/JvpztUZt5E
Investors like the $RXO deal for the 3PL. At about 6:45 am, stock was reported up about 11.8% to $22.60. The company has tended to trade in a fairly tight range in the last 52 weeks, low of $16.94 on 11/1 and high of $24.33 on 12/27. Slight rise at $UPS, nothing unusual. https://t.co/dvZWpdO83B